General Medicine and Primary Care

Host: Matt Birnholz, MD

Dr. Matt Birnholz reviews more nominees for our Heroes in Healthcare program and what their peers have to say about their efforts.

Host: Hector O. Chapa, MD, FACOG

Guest: Joshua D. Lee MD, MSc

2021 brought revived hope to the opioid crisis battle with the Department of Health and Human Services' announcement of a plan to drop the X-waiver requirement for buprenorphine prescriptions. How might this elimination and other new developments help us win the battle against opioid addiction? Explore this question and more with Dr. Hector Chapa and Dr. Joshua Lee, Director of the NYU Fellowship in Addiction Medicine.

Host: Matt Birnholz, MD

In celebration of our “Heroes in Healthcare,” Dr. Matt Birnholz continues to commend our nominees for their valuable contributions to the field of medicine, taking strides to save lives and make a difference during the COVID-19 pandemic.

Host: Andrew Wilner, MD, FACP, FAAN

Guest: Ken Tyler, MD

Further complicating the COVID-19 pandemic is the emergence of viral variants. Dr. Ken Tyler from the University of Colorado School of Medicine shares with us what we know so far about the COVID-19 variants that are quickly spreading around the world.

Host: John E. Anderson, MD

Guest: Matthias Hebrok, PhD

Emerging research may offer clinicians an alternative approach to treating type 1 diabetes. Dr. John Anderson meets with Dr. Matthias Hebrok, a professor in diabetes research and director of the Diabetes Center at the University of California, San Francisco, to discuss his groundbreaking research on insulin-producing stem cells.

Host: John E. Anderson, MD

Guest: Matthias Hebrok, PhD

What are the effects of type 1 diabetes on the body? Dr. Matthias Hebrok, a professor in diabetes research and director of the Diabetes Center at the University of California, San Francisco shares some insight on type 1 diabetes and its chronic impact on patients.

Host: Carol Wysham

Guest: Alexis McKee, MD

Patient care has evolved amid the COVID-19 pandemic, causing unexpected challenges in managing diseases such as diabetes. Dr. Carol Wysham joins Dr. Alexis McKee, a practicing endocrinologist and an assistant professor of medicine at Washington School of Medicine in St. Louis, Missouri, to discuss how patients have been overcoming challenges in managing diabetes during the pandemic.

Host: Jacob Sands, MD

Guest: Benjamin Levy, MD

What is genomic testing, and how has this advancement become such an important part of lung cancer treatment? Dr. Jacob Sands is joined Dr. Ben Levy, an associate professor of oncology at the Johns Hopkins University School of Medicine to discuss targeted therapies and testing strategies in patients with lung cancer.

Host: Peter Buch, MD, FACG, AGAF, FACP

Guest: Paul Feuerstadt, MD, FACG, AGAF

Clostridium difficile impacts many patients around the United States. How can we better diagnose and treat this infection? Dr. Peter Buch is joined by Dr. Paul Feuerstadt, Assistant Clinical Professor of Medicine at Yale New Haven Hospital the discuss the importance of managing Clostridium difficile.

Host: Jacob Sands, MD

Guest: Lawrence Nathan Shulman, MD

How do challenges in our healthcare system and disparities in access to care impact cancer patients within our communities? Dr. Jacob Sands and Dr. Lawrence Shulman continue their important conversation on oncology around the world.